Intelligent anti-aging skin care based on independent research     
Lose wrinkles, keep your bank account!     
 
Skin Care 101
Skin Care Basics
Skin Protection
Skin Biology
Biology of Aging
Ingredient Guide
Skin & Nutrition
Skin Conditions
 
Anti-Aging Treatments
Topical Actives
Wrinkle Fillers
Noninvasive
Invasive
 
Skin Care Smarts
Smart Choices
Best Practices
Find Good Skin Doc
Quick Tips
Freebie Finder
 
Reviews & Research
Product Reviews
Provider Reviews
Skin Care Research
Clinical Trials
 
How-To Infopacks
Skin Rejuvenation
DIY Skin Care
Skin & Nutrition
Eye Skin Care
Longevity In a Pill
 
Community & Misc
Forums
Polls & Surveys
News and Updates
Search

-- advertisements --
   
You are here: Clinical Trials >

Treatment of Melasma With Jessner's Solution Vs. Trichloroacetic Acid

Information provided by Emory University
Information obtained from ClinicalTrials.gov on June 16, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) treated: Melasma

Intervention: Jessner's solution chemical peel (Procedure); Trichloroacetic acid chemical peel (Procedure)

Phase: Phase 4

Enrollment status: Recruiting

Sponsor: Emory University

Principal investigator(s) or official(s):
Carl Washington, MD, Principal Investigator, Affiliation: Emory University Department of Dermatology

Overall contact:
Carl Washington, MD, Phone: 404-778-3354, Email: cwashin@emory.edu

Summary

Melasma is an acquired discoloration of the skin characterized by brown patches. Chemical peels using agents such as Jessner's solution and trichloroacetic acid (TCA) are commonly used to treat melasma. A chemical peel involves applying the peeling agent to the skin for a short period. The skin will peel similar to a sunburn, and moisturizers are applied to the skin. Although both agents are well-accepted, there have been no good comparisons of the two agents. The purpose of this study is determine if there is a difference in the effectiveness of these two agents.

Clinical Details

Official title: Treatment of Melasma With Jessner's Solution Vs. Trichloroacetic Acid: A Comparison of Clinical Efficacy

Study design: Treatment, Non-Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study

Primary outcome: Clinical efficacy by clinician's evaluation

Secondary outcome: Efficacy by subject's evaluation

Eligibility

Minimum eligible age: 18 Years. Eligible gender(s): Both.

Criteria:

Inclusion Criteria:

- Adults > 18 years old

- Clinical diagnosis of melasma

- Mental capacity to give informed consent

Exclusion Criteria:

- Pregnancy

- H/o allergy to Jessner's solution, tricholoracetetic acid, tretinoin, or hydroquinone

- Active dermatitis

- Presence of cutaneous infection

Locations and Contact Information

Carl Washington, MD, Phone: 404-778-3354, Email: cwashin@emory.edu

Emory University Dermatology Clinic, Atlanta, Georgia 30322, United States; Recruiting
Lynae Stewart, Phone: 404-778-4827
Carl Washington, MD, Principal Investigator
Tracy Bialy, MD, Sub-Investigator
Tanda Lane, MD, Sub-Investigator
Additional Information

Start date: January 2004
Last updated: September 13, 2005


Google
 
Web SmartSkinCare.com

Home | About Us | Contact Us | Ask a Question | Resources

Copyright © 1999-2008 by Dr. G. Todorov / SmartSkinCare.com
Site Disclaimer | Copyright Certification

   
-- advertisements --